Noetik
South San Francisco
About Noetik
Noetik is an AI-native biotechnology company that applies self-supervised machine learning to large-scale human multimodal spatial omics datasets with the aim of developing precision cancer therapies. Its platform combines high-throughput in vivo CRISPR “Perturb-Map” screening with foundation models like OCTO, which integrates data from proteomics, transcriptomics, DNA sequencing, and histopathology to simulate tumor and immune-cell behavior.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $55.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Sep 2024)
- Website: noetik.ai
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/noetik-52262 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.